drugset / Trial / NCT01075412

FLT PET Imaging for Cervical Cancer

NCT01075412

RandomizedParallel-groupOpen-labelTreatment

Summary

Our primary hypothesis is that \[18F\]FLT PET can identify active bone marrow in addition to metabolically active tumor. This trial will use FLT-PET imaging to define areas of active bone marrow in the pelvis. The radiation plan is then designed to spare that area, in hopes of keeping the bone marrow active during therapy. Bone marrow and tumor activity will be monitored using a sequence of FLT PET scans during the course of chemotherapy and radiation therapy.

Timeline

Start
2009-09
Primary completion
2016-03-03
Completion
2016-04-11

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject 18F-FLT Diagnostic / imaging agent 185 mbq

Indications